What’s New in Sepsis
Dr Kamal Bharathi. S
Department of Pulmonary Medicine
Sri Manakula Vinayagar Medical college and Hospital
What is new in sepsis
What is new in sepsis
What is new in sepsis
What is new in sepsis
SEPSIS
• The clinical criteria for sepsis include suspected
or documented infection and an acute increase of
two or more Sequential Organ Failure Assessment
(SOFA) points as a proxy for organ dysfunction.
• This new definition emphasizes the primacy of
the non-homeostatic host response to infection,
the potential lethality that is considerably in
excess of a straightforward infection, and the
need for urgent recognition.
Sepsis vs Septic Shock
The Sequential Organ Failure
Assessment (SOFA) Score
• A clinical evaluation of the patient that includes
laboratory values is needed to calculate a SOFA
score. The SOFA score is most commonly used in the
ICU practice setting.
The following are the abnormal physiologic SOFA
parameters, each of which receives a score of 2 or higher:
• PaO2:FiO2, < 300 mmHg
• Platelets < 100 × 103/mm3
• Bilirubin ≥ 2 mg/dL
• Hypotension requiring vasopressor support
• Glasgow Coma Scale score ≤ 12
• Creatinine ≥ 2 mg/dL, or urine output < 500 mL/day.
SOFA Score
The Quick Sequential Organ Failure
Assessment (qSOFA) Score
The following are the abnormal physiologic qSOFA parameters:
• systolic blood pressure, ≤ 100 mmHg
• respiratory rate, ≥ 22 breaths per minute
• any change in mental status
Non-ICU patients with a total score of 2 or 3 are considered at elevated
risk for an extended ICU stay or death and should be assessed for
evidence of organ dysfunction using the SOFA.
MEWS & NEWS
Logistic Organ Dysfunction Score
SIRS versus SOFA and qSOFA in Sepsis
• Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, Pilcher DV. Prognostic accuracy of the SOFA score, SIRS
criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit.
Jama. 2017 Jan 17;317(3):290-300.
"Time zero” or “time of presentation” is defined as the time of
triage in the emergency department or, if referred from another
care location, from the earliest chart annotation consistent with
all elements of sepsis (formerly severe sepsis) or septic shock
ascertained through chart review."
Surviving Sepsis Campaign Bundle:
2018 Update
HOUR-1 BUNDLE
• The most important change in the
revision of the SSC bundles is that the 3-h
and 6-h bundles have been combined
into a single “hour-1 bundle” with the
explicit intention of beginning
resuscitation and management
immediately.
HOUR-1 BUNDLE
• Measure lactate level. Re-measure if initial
lactate is >2 mmol/L.
• Obtain blood cultures prior to administration of
antibiotics.
• Administer broad-spectrum antibiotics.
• Begin rapid administration of 30m1/kg crystalloid
for hypotension or lactate > 4 mmol/L.
• Apply vasopressors if patient is hypotensive
during or after fluid resuscitation to maintain
MAP 65 mm Hg.
3-h and 6-h bundles
TO BE COMPLETED WITHIN 3 HOURS:
1) Measure lactate level
2) Obtain blood cultures prior to administration of antibiotics
3) Administer broad spectrum antibiotics
4) Administer 30 mL/kg crystalloid for hypotension or lactate 4mmol/L
TO BE COMPLETED WITHIN 6 HOURS:
5) Apply vasopressors (for hypotension that does not respond to initial fluid
resuscitation to maintain a mean arterial pressure [MAP] 65 mm Hg)
6) In the event of persistent arterial hypotension despite volume resuscitation
(septic shock) or initial lactate ≥ 4 mmol/L (36 mg/dL):
- Measure central venous pressure (CVP)
- Measure central venous oxygen saturation (ScvO2)
7) Re-measure lactate if initial lactate was elevated.
Measure Lactate Level
• Increases may represent tissue hypoxia,
accelerated aerobic glycolysis driven by excess
beta-adrenergic stimulation, or other causes
associated with worse outcomes.
• A significant reduction in mortality with lactate
guided resuscitation (24−28).
• If initial lactate is elevated (> 2mmol/L), it should
be remeasured within 2−4 h to guide
resuscitation to normalize lactate in patients with
elevated lactate levels as a marker of tissue
hypoperfusion.
Blood Cultures
• Sterilization of cultures can occur
within minutes of the first dose of
an appropriate antimicrobial, so
cultures must be obtained before
antibiotic administration to
optimize the identification of
pathogens and improve outcomes.
• Appropriate blood cultures
include at least two sets (aerobic
and anaerobic).
• 1 -percutaneously
1 -drawn through each vascular
access device
What is new in sepsis
Hemodynamic Support
and Adjunctive
Therapy
Antimicrobial Therapy
• Administration of effective IV antimicrobials
within the 1st hour of recognition.
a) Initial empiric anti-infective therapy of one or
more drugs that have activity against all likely
pathogens & that penetrate in adequate
concentrations into tissues.
b) Empiric combination therapy should not be
administered for more than 3–5 days
c) Antimicrobial regimen should be reassessed
daily for potential de-escalation.
Procalcitonin
• Rises with bacterial infections (not viral!!!)
• Precursor to calcitonin (responsible for calcium homeostasis)
• Normal level is < 10 pg/ml (< 0.5 ng/ml)
• 0.5 – 2 ng/ml “grey zone” (repeat level in 6 – 24 hrs)
• > 10 ng/ml associated with severe sepsis/shock
• Half life of 25 – 30 hours
• Discontinue/ taper antibiotics
• 2 meta-analysis CAP
• 6 days antibiotics (treatment group) vs 10 days (control)
We suggest that measurement of procalcitonin levels can be used to
support shortening the duration of antimicrobial therapy
Combination empirical therapy
• Beta-lactam and either an aminoglycoside or a
fluoroquinolone is for P. aeruginosa
bacteremia.
• Beta-lactam and macrolide for bacteremic
Streptococcus pneumoniae infections.
Fluid Therapy
• Crystalloids as the initial fluid of choice in the
resuscitation of severe sepsis and septic shock.
• Albumin - when patients require substantial amounts
of crystalloids.
• Initial fluid challenge in patients with sepsis-induced
tissue hypoperfusion with suspicion of hypovolemia to
achieve a minimum of 30 mL/kg of crystalloids (a
portion of this may be albumin equivalent).
• Continued as long as there is hemodynamic
improvement either based on dynamic (eg, change in
pulse pressure, stroke volume variation) or static (eg,
arterial pressure, heart rate) variables.
Vasopressors
• Vasopressor therapy initially to target a mean arterial
pressure (MAP) of 65 mm Hg.
• Norepinephrine as the first choice vasopressor.
• Epinephrine (added to and potentially substituted for
norepinephrine) when an additional agent is needed to
maintain adequate blood pressure.
• Vasopressin 0.03 units/minute can be added to
norepinephrine (NE) with intent of either raising MAP or
decreasing NE dosage.
• Dopamine as an alternative vasopressor agent to
norepinephrine only in highly selected patients (eg,
patients with low risk of tachyarrhythmias and absolute or
relative bradycardia)
Inotropic Therapy
• A trial of dobutamine infusion up to 20
micrograms/kg/min be administered or added
to vasopressor (if in use) in the presence of
(a) myocardial dysfunction as suggested by
elevated cardiac filling pressures and low cardiac
output, or
(b) ongoing signs of hypoperfusion, despite
achieving adequate intravascular volume and
adequate MAP.
Supportive Therapy of
Severe Sepsis
Mechanical Ventilation of Sepsis-
Induced ARDS
• Target a tidal volume of 6 mL/kg predicted
body weight in patients with sepsis-induced
ARDS.
• Initial upper limit goal for plateau pressures in
a passively inflated lung be ≤30 cm H2O.
• PEEP be applied to avoid alveolar collapse at
end expiration.
Blood Product Administration
• Hemoglobin concentration decreases to <7.0
g/dL to target a hemoglobin concentration of
7.0 –9.0 g/dL in adults.
• Prophylactic platelet transfusion when counts
are < 20,000/mm3 (20 x 109/L) if the patient
has a significant risk of bleeding.
Sedation, Analgesia, and
Neuromuscular Blockade
• Continuous or intermittent sedation be
minimized in mechanically ventilated sepsis
patients, targeting specific titration endpoints.
• A short course of NMBA of not greater than 48
hours for patients with early sepsis-induced
ARDS and a Pao2/Fio2 < 150 mm Hg
• Glucose Control: Target an upper blood
glucose ≤180 mg/dL rather than an upper
target blood glucose ≤ 110 mg/dL.
• Renal Replacement Therapy (RRT):
Continuous RRT and intermittent hemodialysis
are equivalent in patients with severe sepsis
and acute renal failure.
• Bicarbonate Therapy: in hypoperfusion-
induced lactic acidemia with pH ≥7.15
• Deep Vein Thrombosis Prophylaxis: daily
subcutaneous (LMWH) against venous
thromboembolism (VTE).
• Stress Ulcer Prophylaxis: using H2 blocker or proton
pump inhibitor.
• Prone position for sepsis-induced ARDS with
PaO2/FiO2 ratio <150.
• Elevate head of bed 30–45 degrees in mechanically
ventilated patients, spontaneous breathing trials, and a
weaning protocol.
• Early enteral nutrition, against parenteral nutrition in
the first 7 d
SSC recommends AGAINST
• Low dose Dopamine for renal protection
• Steroids (Only if on vasopressors – hydrocortisone
200mg/day)
• Erythropoietin for sepsis related anemia
• IV Immunoglobulins for sepsis or septic shock
• High frequency oscillatory ventilation (HFOV) for sepsis
induced ARDS
• ß2 agonists for sepsis-induced ARDS without
bronchospasm
• PA Catheter for patients with sepsis-induced ARDS
• Sodium bicarb therapy to improve
hemodynamics or to reduce vasopressor
requirements
• Stress ulcer prophylaxis in patients without risk
factors for GI bleeding!
• Parenteral nutrition alone or in combination with
enteral feedings
• Monitoring gastric residual volumes (only in
feeding intolerance or high risk aspiration)
• IV selenium, glutamine or arginine
Thank you…!!!

More Related Content

PPTX
Sepsis update 2021
PPTX
Surviving Sepsis Campaign 2021 guidelines.pptx
PPTX
Sepsis and septic shock guidelines 2021. part 1
PPTX
Article presentation / Surviving sepsis campaign: international guidelines fo...
PPTX
Sepsis guidelines
PPTX
PPT
Sepsis And Septic Shock
Sepsis update 2021
Surviving Sepsis Campaign 2021 guidelines.pptx
Sepsis and septic shock guidelines 2021. part 1
Article presentation / Surviving sepsis campaign: international guidelines fo...
Sepsis guidelines
Sepsis And Septic Shock

What's hot (20)

PPTX
Septic shock management (1)
PPTX
surviving sepsis campaign - latest guideline.pptx
PPTX
Sepsis 2017
PPTX
Sepsis management guidelines (SSC) 2018/2019
PPT
PPTX
Sepsis – pathophysiology and management
PPTX
Sepsis, Septic Shock and Surviving Sepsis Guidelines
PPTX
Potassium Management
PPTX
Management of sepsis
PPTX
hypernatremia
PPTX
Septic shock
PPTX
Potassium imbalance and management
PPTX
ABG and spirometry
PPTX
Approach to a patient in shock
PPTX
Surviving Sepsis Guidelines Updated
PPTX
Sepsis and septic shock
PPTX
Sepsis In critical care 2019 final
PPTX
Sepsis and septic shock
Septic shock management (1)
surviving sepsis campaign - latest guideline.pptx
Sepsis 2017
Sepsis management guidelines (SSC) 2018/2019
Sepsis – pathophysiology and management
Sepsis, Septic Shock and Surviving Sepsis Guidelines
Potassium Management
Management of sepsis
hypernatremia
Septic shock
Potassium imbalance and management
ABG and spirometry
Approach to a patient in shock
Surviving Sepsis Guidelines Updated
Sepsis and septic shock
Sepsis In critical care 2019 final
Sepsis and septic shock
Ad

Similar to What is new in sepsis (20)

PPTX
Approach to Management of Fever & Sepsis (2) copy.pptx
PPTX
Emergency medicine sepsis and septic shock ppt pptx
PPT
Perforation - Interactive case on Septic Shock
PPTX
Severe sepsis and septic shock :evaluation and management
PPTX
IV%20FLUIDS.pptx
PDF
Room a b01. mcgee-new sepsis_(en)
 
PPTX
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
PPT
Bundle of sepsis
PPT
Surviving sepsis Guidelines 2012
PPT
CME: Management of Severe Sepsis & Septic Shock
PPT
Septic shock management
PPTX
Surviving Sepsis Guidelines 2016
PPTX
SURVIVING SEPSIS COMPAIGN
PPTX
Sepsis 4 a to z(u) in sepsis management
PPTX
Critical care nephrology 26 6-2020
PPT
sepsis.pptcme.ppt
PPTX
Septic shock copy
PPTX
Managing sepsis and septic shock 1
PPT
suviving-sepsis- SIRS and sepsis ppt.ppt
PPTX
sepsis.pptx
Approach to Management of Fever & Sepsis (2) copy.pptx
Emergency medicine sepsis and septic shock ppt pptx
Perforation - Interactive case on Septic Shock
Severe sepsis and septic shock :evaluation and management
IV%20FLUIDS.pptx
Room a b01. mcgee-new sepsis_(en)
 
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
Bundle of sepsis
Surviving sepsis Guidelines 2012
CME: Management of Severe Sepsis & Septic Shock
Septic shock management
Surviving Sepsis Guidelines 2016
SURVIVING SEPSIS COMPAIGN
Sepsis 4 a to z(u) in sepsis management
Critical care nephrology 26 6-2020
sepsis.pptcme.ppt
Septic shock copy
Managing sepsis and septic shock 1
suviving-sepsis- SIRS and sepsis ppt.ppt
sepsis.pptx
Ad

More from Kamal Bharathi (18)

PPTX
Pneumonia
PPTX
Tappcon 2019 grand rounds
PPTX
Neurogenic Pulmonary Edema
PPTX
Obstructive Sleep Apnea
PPTX
Chest Wall Deformity
PPTX
Interstitial Lung Disease
PPTX
Ventilation perfusion relationships
PPTX
Malignant pleural effusions
PPTX
Smoking cessation
PPTX
HIGH ALTITUDE PHYSIOLOGY
PPTX
DIAGNOSIS & MANAGEMENT OF PULMONARY HYPERTENSION
PPTX
CLASSIFICATION OF LUNG TUMORS
PPTX
ANTIBIOTICS IN SPECIAL CONDITIONS
PPTX
Asbestos related lung disease
PPTX
Mechanism of breathing
PPTX
Cough evaluation
PPTX
CHEST X-RAY
PPTX
ARTERIAL BLOOD GAS
Pneumonia
Tappcon 2019 grand rounds
Neurogenic Pulmonary Edema
Obstructive Sleep Apnea
Chest Wall Deformity
Interstitial Lung Disease
Ventilation perfusion relationships
Malignant pleural effusions
Smoking cessation
HIGH ALTITUDE PHYSIOLOGY
DIAGNOSIS & MANAGEMENT OF PULMONARY HYPERTENSION
CLASSIFICATION OF LUNG TUMORS
ANTIBIOTICS IN SPECIAL CONDITIONS
Asbestos related lung disease
Mechanism of breathing
Cough evaluation
CHEST X-RAY
ARTERIAL BLOOD GAS

Recently uploaded (20)

PPTX
Approch to weakness &paralysis pateint.pptx
PPTX
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
PPTX
A Detailed Physiology of Endocrine System.pptx
PPT
Medical Emergencies in Maxillofacial_Surgery.ppt
PPTX
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
DOCX
ORGAN SYSTEM DISORDERS Zoology Class Ass
PDF
Demography and community health for healthcare.pdf
PPTX
Local Anesthesia Local Anesthesia Local Anesthesia
PPSX
Man & Medicine power point presentation for the first year MBBS students
PPTX
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
PDF
The Role of Medicinal Plants in Alleviating Symptoms of Diabetes-Related Com...
PPTX
Indications for Surgical Delivery...pptx
PDF
periodontaldiseasesandtreatments-200626195738.pdf
PDF
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
PDF
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
PPTX
المحاضرة الثالثة Urosurgery (Inflammation).pptx
PPTX
ENT-DISORDERS ( ent for nursing ). (1).p
PPTX
ACUTE PANCREATITIS combined.pptx.pptx in kids
PPTX
This book is about some common childhood
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
Approch to weakness &paralysis pateint.pptx
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
A Detailed Physiology of Endocrine System.pptx
Medical Emergencies in Maxillofacial_Surgery.ppt
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
ORGAN SYSTEM DISORDERS Zoology Class Ass
Demography and community health for healthcare.pdf
Local Anesthesia Local Anesthesia Local Anesthesia
Man & Medicine power point presentation for the first year MBBS students
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
The Role of Medicinal Plants in Alleviating Symptoms of Diabetes-Related Com...
Indications for Surgical Delivery...pptx
periodontaldiseasesandtreatments-200626195738.pdf
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
المحاضرة الثالثة Urosurgery (Inflammation).pptx
ENT-DISORDERS ( ent for nursing ). (1).p
ACUTE PANCREATITIS combined.pptx.pptx in kids
This book is about some common childhood
neonatology-for-nurses.pdfggghjjkkkkkkjhhg

What is new in sepsis

  • 1. What’s New in Sepsis Dr Kamal Bharathi. S Department of Pulmonary Medicine Sri Manakula Vinayagar Medical college and Hospital
  • 6. SEPSIS • The clinical criteria for sepsis include suspected or documented infection and an acute increase of two or more Sequential Organ Failure Assessment (SOFA) points as a proxy for organ dysfunction. • This new definition emphasizes the primacy of the non-homeostatic host response to infection, the potential lethality that is considerably in excess of a straightforward infection, and the need for urgent recognition.
  • 8. The Sequential Organ Failure Assessment (SOFA) Score • A clinical evaluation of the patient that includes laboratory values is needed to calculate a SOFA score. The SOFA score is most commonly used in the ICU practice setting. The following are the abnormal physiologic SOFA parameters, each of which receives a score of 2 or higher: • PaO2:FiO2, < 300 mmHg • Platelets < 100 × 103/mm3 • Bilirubin ≥ 2 mg/dL • Hypotension requiring vasopressor support • Glasgow Coma Scale score ≤ 12 • Creatinine ≥ 2 mg/dL, or urine output < 500 mL/day.
  • 10. The Quick Sequential Organ Failure Assessment (qSOFA) Score The following are the abnormal physiologic qSOFA parameters: • systolic blood pressure, ≤ 100 mmHg • respiratory rate, ≥ 22 breaths per minute • any change in mental status Non-ICU patients with a total score of 2 or 3 are considered at elevated risk for an extended ICU stay or death and should be assessed for evidence of organ dysfunction using the SOFA.
  • 13. SIRS versus SOFA and qSOFA in Sepsis • Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, Pilcher DV. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. Jama. 2017 Jan 17;317(3):290-300.
  • 14. "Time zero” or “time of presentation” is defined as the time of triage in the emergency department or, if referred from another care location, from the earliest chart annotation consistent with all elements of sepsis (formerly severe sepsis) or septic shock ascertained through chart review."
  • 15. Surviving Sepsis Campaign Bundle: 2018 Update HOUR-1 BUNDLE • The most important change in the revision of the SSC bundles is that the 3-h and 6-h bundles have been combined into a single “hour-1 bundle” with the explicit intention of beginning resuscitation and management immediately.
  • 16. HOUR-1 BUNDLE • Measure lactate level. Re-measure if initial lactate is >2 mmol/L. • Obtain blood cultures prior to administration of antibiotics. • Administer broad-spectrum antibiotics. • Begin rapid administration of 30m1/kg crystalloid for hypotension or lactate > 4 mmol/L. • Apply vasopressors if patient is hypotensive during or after fluid resuscitation to maintain MAP 65 mm Hg.
  • 17. 3-h and 6-h bundles TO BE COMPLETED WITHIN 3 HOURS: 1) Measure lactate level 2) Obtain blood cultures prior to administration of antibiotics 3) Administer broad spectrum antibiotics 4) Administer 30 mL/kg crystalloid for hypotension or lactate 4mmol/L TO BE COMPLETED WITHIN 6 HOURS: 5) Apply vasopressors (for hypotension that does not respond to initial fluid resuscitation to maintain a mean arterial pressure [MAP] 65 mm Hg) 6) In the event of persistent arterial hypotension despite volume resuscitation (septic shock) or initial lactate ≥ 4 mmol/L (36 mg/dL): - Measure central venous pressure (CVP) - Measure central venous oxygen saturation (ScvO2) 7) Re-measure lactate if initial lactate was elevated.
  • 18. Measure Lactate Level • Increases may represent tissue hypoxia, accelerated aerobic glycolysis driven by excess beta-adrenergic stimulation, or other causes associated with worse outcomes. • A significant reduction in mortality with lactate guided resuscitation (24−28). • If initial lactate is elevated (> 2mmol/L), it should be remeasured within 2−4 h to guide resuscitation to normalize lactate in patients with elevated lactate levels as a marker of tissue hypoperfusion.
  • 19. Blood Cultures • Sterilization of cultures can occur within minutes of the first dose of an appropriate antimicrobial, so cultures must be obtained before antibiotic administration to optimize the identification of pathogens and improve outcomes. • Appropriate blood cultures include at least two sets (aerobic and anaerobic). • 1 -percutaneously 1 -drawn through each vascular access device
  • 22. Antimicrobial Therapy • Administration of effective IV antimicrobials within the 1st hour of recognition. a) Initial empiric anti-infective therapy of one or more drugs that have activity against all likely pathogens & that penetrate in adequate concentrations into tissues. b) Empiric combination therapy should not be administered for more than 3–5 days c) Antimicrobial regimen should be reassessed daily for potential de-escalation.
  • 23. Procalcitonin • Rises with bacterial infections (not viral!!!) • Precursor to calcitonin (responsible for calcium homeostasis) • Normal level is < 10 pg/ml (< 0.5 ng/ml) • 0.5 – 2 ng/ml “grey zone” (repeat level in 6 – 24 hrs) • > 10 ng/ml associated with severe sepsis/shock • Half life of 25 – 30 hours • Discontinue/ taper antibiotics • 2 meta-analysis CAP • 6 days antibiotics (treatment group) vs 10 days (control) We suggest that measurement of procalcitonin levels can be used to support shortening the duration of antimicrobial therapy
  • 24. Combination empirical therapy • Beta-lactam and either an aminoglycoside or a fluoroquinolone is for P. aeruginosa bacteremia. • Beta-lactam and macrolide for bacteremic Streptococcus pneumoniae infections.
  • 25. Fluid Therapy • Crystalloids as the initial fluid of choice in the resuscitation of severe sepsis and septic shock. • Albumin - when patients require substantial amounts of crystalloids. • Initial fluid challenge in patients with sepsis-induced tissue hypoperfusion with suspicion of hypovolemia to achieve a minimum of 30 mL/kg of crystalloids (a portion of this may be albumin equivalent). • Continued as long as there is hemodynamic improvement either based on dynamic (eg, change in pulse pressure, stroke volume variation) or static (eg, arterial pressure, heart rate) variables.
  • 26. Vasopressors • Vasopressor therapy initially to target a mean arterial pressure (MAP) of 65 mm Hg. • Norepinephrine as the first choice vasopressor. • Epinephrine (added to and potentially substituted for norepinephrine) when an additional agent is needed to maintain adequate blood pressure. • Vasopressin 0.03 units/minute can be added to norepinephrine (NE) with intent of either raising MAP or decreasing NE dosage. • Dopamine as an alternative vasopressor agent to norepinephrine only in highly selected patients (eg, patients with low risk of tachyarrhythmias and absolute or relative bradycardia)
  • 27. Inotropic Therapy • A trial of dobutamine infusion up to 20 micrograms/kg/min be administered or added to vasopressor (if in use) in the presence of (a) myocardial dysfunction as suggested by elevated cardiac filling pressures and low cardiac output, or (b) ongoing signs of hypoperfusion, despite achieving adequate intravascular volume and adequate MAP.
  • 29. Mechanical Ventilation of Sepsis- Induced ARDS • Target a tidal volume of 6 mL/kg predicted body weight in patients with sepsis-induced ARDS. • Initial upper limit goal for plateau pressures in a passively inflated lung be ≤30 cm H2O. • PEEP be applied to avoid alveolar collapse at end expiration.
  • 30. Blood Product Administration • Hemoglobin concentration decreases to <7.0 g/dL to target a hemoglobin concentration of 7.0 –9.0 g/dL in adults. • Prophylactic platelet transfusion when counts are < 20,000/mm3 (20 x 109/L) if the patient has a significant risk of bleeding.
  • 31. Sedation, Analgesia, and Neuromuscular Blockade • Continuous or intermittent sedation be minimized in mechanically ventilated sepsis patients, targeting specific titration endpoints. • A short course of NMBA of not greater than 48 hours for patients with early sepsis-induced ARDS and a Pao2/Fio2 < 150 mm Hg
  • 32. • Glucose Control: Target an upper blood glucose ≤180 mg/dL rather than an upper target blood glucose ≤ 110 mg/dL. • Renal Replacement Therapy (RRT): Continuous RRT and intermittent hemodialysis are equivalent in patients with severe sepsis and acute renal failure. • Bicarbonate Therapy: in hypoperfusion- induced lactic acidemia with pH ≥7.15
  • 33. • Deep Vein Thrombosis Prophylaxis: daily subcutaneous (LMWH) against venous thromboembolism (VTE). • Stress Ulcer Prophylaxis: using H2 blocker or proton pump inhibitor. • Prone position for sepsis-induced ARDS with PaO2/FiO2 ratio <150. • Elevate head of bed 30–45 degrees in mechanically ventilated patients, spontaneous breathing trials, and a weaning protocol. • Early enteral nutrition, against parenteral nutrition in the first 7 d
  • 34. SSC recommends AGAINST • Low dose Dopamine for renal protection • Steroids (Only if on vasopressors – hydrocortisone 200mg/day) • Erythropoietin for sepsis related anemia • IV Immunoglobulins for sepsis or septic shock • High frequency oscillatory ventilation (HFOV) for sepsis induced ARDS • ß2 agonists for sepsis-induced ARDS without bronchospasm • PA Catheter for patients with sepsis-induced ARDS
  • 35. • Sodium bicarb therapy to improve hemodynamics or to reduce vasopressor requirements • Stress ulcer prophylaxis in patients without risk factors for GI bleeding! • Parenteral nutrition alone or in combination with enteral feedings • Monitoring gastric residual volumes (only in feeding intolerance or high risk aspiration) • IV selenium, glutamine or arginine